Procaps Group S.A. (PROCW)
0.05
0.02 (65.02%)
At close: Jan 13, 2025, 9:00 PM
undefined% (undefined)
| Bid | 0.03 |
| Market Cap | 184.01M |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | 0 |
| PE Ratio (ttm) | n/a |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 0.05 |
| Volume | 21 |
| Avg. Volume (20D) | 0 |
| Open | 0.03 |
| Previous Close | 0.03 |
| Day's Range | 0.03 - 0.05 |
| 52-Week Range | 0.03 - 0.05 |
| Beta | undefined |
About PROCW
Procaps Group, S.A. operates as an integrated healthcare and pharmaceutical company worldwide. The company formulates, manufactures, and markets branded prescription drugs in various therapeutic areas, including feminine care products, pain relief, skin care, digestive health, growth and development, cardiology, vision care, central nervous system, and respiratory. It also provides drugs for hospital use, such as antibiotic, blood clot, personal ...
Sector Healthcare
IPO Date Sep 30, 2021
Employees 5,500
Stock Exchange NASDAQ
Ticker Symbol PROCW
Website http://www.procapsgroup.com